lung cancer
Conditions
Interventions
4 groups:Dose-escalation
Sponsors
Shanghai Chest Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Eligible patients with histologically or cytologically confirmed NSCLC, classified as unresectable stage III (according to American Joint Committee on Cancer [AJCC; 6th edition]). Patients must previously untreated, with no prior thoracic radiation or chemotherapy. The age of enrolled patients ranged between 18-75 years old. The Eastern Cooperative Oncology Group (ECOG) performance status (PS) of the patient was 0–1, weight loss was less than 10%, and the expected survival time was more than 3 months.
Exclusion criteria
Exclusion criteria: Patients had another malignant tumor history that had been clinically cured in 5 years Patients who were pregnant, breastfeeding, had severe lung and heart diseases that affected lung function, and could not endure concurrent chemotherapy assessed by a medical oncologist due to medical reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the maximum-tolerable dose (MTD); | — |
Countries
China
Contacts
Public ContactXiaolong Fu
Shanghai Chest Hospital
Outcome results
None listed